J&J Sees 250,000 Ebola Vaccine Doses Ready for Trials in May (1)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers JNJ US (Johnson & Johnson) BAVA DC (Bavarian Nordic A/S) NLNK US (NewLink Genetics Corp)
People Alex Gorsky (Johnson & Johnson)
Topics Viral Illnesses Cancers Medical, Health Research Infectious Diseases
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283